159 related articles for article (PubMed ID: 19499401)
1. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
3. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
4. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).
Benet I; Prosper BF; Marugan I; Lluch A; Arbona C; Castillo I; Solano C; Garcia-Conde J
Bone Marrow Transplant; 1999 Jun; 23(11):1101-7. PubMed ID: 10382948
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
[TBL] [Abstract][Full Text] [Related]
6. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
7. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Hägglund H; Ringdén O; Remberger M; Lönnqvist B; Sparrelid E; Tammik L; Kumlien G
Bone Marrow Transplant; 1998 Jul; 22(2):131-6. PubMed ID: 9707019
[TBL] [Abstract][Full Text] [Related]
8. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
[TBL] [Abstract][Full Text] [Related]
9. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
Bolwell B; Goormastic M; Andresen S; Koo A; Wise K; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1998 Sep; 22(6):547-51. PubMed ID: 9758341
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
Bolwell BJ; Goormastic M; Andresen S; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
[TBL] [Abstract][Full Text] [Related]
11. Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma.
Goldschmidt H; Hegenbart U; Moos M; Eugenhart R; Wannenmacher M; Haas R; Hunstein W
Stem Cells; 1995 Dec; 13 Suppl 3():36-41. PubMed ID: 8747987
[TBL] [Abstract][Full Text] [Related]
12. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.
Bolwell BJ; Pohlman B; Andresen S; Kalaycio M; Goormastic M; Wise K; Wakeling A; Dannley R; Overmoyer B
Bone Marrow Transplant; 1998 Feb; 21(4):369-73. PubMed ID: 9509971
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L
Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
[TBL] [Abstract][Full Text] [Related]
14. Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma.
Abonour R; Scott KM; Kunkel LA; Robertson MJ; Hromas R; Graves V; Lazaridis EN; Cripe L; Gharpure V; Traycoff CM; Mills B; Srour EF; Cornetta K
Bone Marrow Transplant; 1998 Nov; 22(10):957-63. PubMed ID: 9849692
[TBL] [Abstract][Full Text] [Related]
15. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE
Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
Martín-Henao GA; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J
Bone Marrow Transplant; 1999 Mar; 23(6):579-87. PubMed ID: 10217189
[TBL] [Abstract][Full Text] [Related]
17. CD34 counts to predict the adequate collection of peripheral blood progenitor cells.
Armitage S; Hargreaves R; Samson D; Brennan M; Kanfer E; Navarrete C
Bone Marrow Transplant; 1997 Oct; 20(7):587-91. PubMed ID: 9337061
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells.
Wiesneth M; Schreiner T; Sandherr M; Maccari B; Erne E; Bischof C; Frickhofen N; von Schilling C; Kubanek B
Beitr Infusionsther Transfusionsmed; 1997; 34():133-8. PubMed ID: 9356664
[TBL] [Abstract][Full Text] [Related]
19. Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.
Weaver CH; Potz J; Redmond J; Tauer K; Schwartzberg LS; Kaywin P; Drapkin R; Grant B; Unger P; Allen C; Longin K; Zhen B; Hazelton B; Buckner CD
Bone Marrow Transplant; 1997 Jun; 19(11):1103-10. PubMed ID: 9193753
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]